Health Care & Life Sciences » Pharmaceuticals | United Laboratories International Holdings Ltd.

United Laboratories International Holdings Ltd.

United Laboratories International Holdings Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD0.37
Market Cap
HKD7.05 B
Shares Outstanding
1.64 B
Public Float
612.09 M

Profile

Address
6 Fuk Wang Street
Hong Kong
Hong Kong
Employees -
Website http://www.tul.com.cn
Updated 07/08/2019
United Laboratories International Holdings Ltd. operates as an investment company, which engages in the manufacturing and sale of medicines, and the bulk and intermediate products used to produce finished goods. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The Intermediate Products segment offers two major products, such as T-Octylammonium Clavulanate and 6-APA.

Financials

View All
Created with Highcharts 5.0.14United Laboratories International Holdings Ltd.Net Income. Fiscal year is January-December. All values HKD Millions.4848681681110110311311949480980920132014201520162017201802004006008001000
Created with Highcharts 5.0.14United Laboratories International Holdings Ltd.Sales/Revenue. Fiscal year is January-December. All values HKD Millions.7 6487 6488 0308 0307 6957 6957 0637 0637 8727 8728 8968 89620132014201520162017201802k4k6k8k10k

Hoi Shan Tsoi
Chairman
Wing Hon Leung
Vice Chairman, Chief Financial Officer & Secretary